4Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009,19(11):1167-1214.
5Hovens GC, Stokkel MP, Kievit J, et al. Associations of serum thyrotropin concentrations with recurrence and death in differen- tiated thyroid cancer [J].J Clin Endocrinol Metab,2007,92(7): 2610-2615.
6Paeini F, Schlumherger M, Oralle H, et al. European consensus for the management of patients with differentiated thyroid carci- noma of the follicular epithelium [ J ]. Eur J Endocrinol,2006,154 (6):787-803.
7Cooper DS, Doherty GM, Haugen BR, et al. Revised manage- ment guidelines for patients with thyroid nodules and differenti- ated thyroid cancer[J]. Thyroid,2009,19(11):1167-1214.
8Kabadi UM, Kabadi MM. Serum thyrotropin in primary hypothy- roidism:a reliable and accurate predictor of optimal daily levo- thyroxine dose[J]. Endocr Praet,2001,7(1):16-18.
9Verhaert N, Vander Poorten V, Delaere P, et al. Levothyroxine replacement therapy after thyroid surgery [J]. B-ENT,2006,2 (13):129-133.
10Roos A, Linn-Rasker SP, Van Domburg RT, et al. The starting dose of levothyroxine in primary hypothyroidism treatment: A prospective, randomized,double-blind trial [J ].Arch Interm Med, 2005,165(15):1714-1720.
